Yu Kataoka
- Molecular Biology
- Oncology
- Pulmonary and Respiratory Medicine
- Radiology, Nuclear Medicine and Imaging
- Cancer Research
- Co-authors
- Hironobu MinamiToru MukoharaHiroyuki ShimadaMitsuharu HiraiNagahiro SaijoHideo TomiokaYohei FunakoshiNaomi Kiyota
- Topics
- PI3K/AKT/mTOR signaling in cancer (5 papers)Phagocytosis and Immune Regulation (3 papers)Liver physiology and pathology (2 papers)
- Cited by
- OncologyHepatologyCancer Research
- Partner nations
- Japan
In The Last Decade
Yu Kataoka
9 papers receiving 372 citations
Peers
Comparison fields: 5 of 44
- Molecular Biology 213
- Oncology 176
- Pulmonary and Respiratory Medicine 99
- Radiology, Nuclear Medicine and Imaging 73
- Cancer Research 50
Countries citing papers authored by Yu Kataoka
This map shows the geographic impact of Yu Kataoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Kataoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Kataoka more than expected).
Fields of papers citing papers by Yu Kataoka
This network shows the impact of papers produced by Yu Kataoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Kataoka. The network helps show where Yu Kataoka may publish in the future.
Co-authorship network of co-authors of Yu Kataoka
This figure shows the co-authorship network connecting the top 25 collaborators of Yu Kataoka. A scholar is included among the top collaborators of Yu Kataoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Kataoka. Yu Kataoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | TYRO3 as a potential therapeutic target in breast cancer. | 28 |
| 4 | 4 | |
| 5 | 21 | |
| 6 | 1 | |
| 7 | 18 | |
| 8 | 22 | |
| 9 | 102 | |
| 10 | 181 |
About Yu Kataoka
Yu Kataoka is a scholar working on Hepatology, Immunology and Allergy and Immunology, having authored 10 papers that have together received 378 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (5 papers), Phagocytosis and Immune Regulation (3 papers) and Liver physiology and pathology (2 papers). The work is most often cited by research in Oncology (176 citations), Hepatology (43 citations) and Cancer Research (50 citations). Yu Kataoka has collaborated with scholars based in Japan. Frequent co-authors include Hironobu Minami, Toru Mukohara, Hiroyuki Shimada, Mitsuharu Hirai, Nagahiro Saijo, Hideo Tomioka, Yohei Funakoshi, Naomi Kiyota, Yutaka Fujiwara and Midori Hirai. Their work appears in journals such as Annals of Oncology, Molecular Cancer Therapeutics and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.